Endoscopic treatment in peptic stenosis
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S419
DOI: 10.1055/s-0044-1783751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von H. Cherkaoui und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Oesophageal peptic stenosis (PS), a benign and infrequent consequence of chronic gastroesophageal reflux disease (GERD), is a condition where upper digestive endoscopy assumes a pivotal role in both diagnosis and therapy. This study endeavors to delineate the epidemiological, endoscopic, and evolving facets of PS.
Methods
Conducted retrospectively over an expansive 18-year span from January 2002 to August 2020, this study encompasses individuals diagnosed with PS. Dilatation procedures were executed using Savary-Gilliard candles or hydrostatic balloons Results A total of 137 patients were included, with an average age of 50.2 years (16-88 years) and a slight male predominance (sex ratio M/F of 1.15). One hundred and twenty-nine dilatation procedures transpired. Chronic GERD history was prevalent in 77% of patients, enduring an average duration of 6 years (1-17 years). The primary reason for patient consultation was dysphagia in all cases, accompanied by regurgitation in 77% and pyrosis in 25%, leading to general state repercussions such as dehydration and undernutrition in 26%. Upper digestive endoscopy revealed an impassable stenosis in 74.5% and a surmountable stenosis in 25.5%, primarily located in the lower 1/3 of the esophagus (75%), with an average stenosis extent of 3.5 cm. All patients were prescribed proton pump inhibitors (PPI). Dilatation was performed in 63% of patients using candles with progressive diameters (average 1.6 [1-11]) and in 37.2% using balloons (average 2.6 sessions [1-10]). Evolution showcased clinical improvement in 64.7% of patients, with recurrence in 30%, necessitating additional endoscopic dilatation sessions. No complications were reported.
Conclusions
Peptic stenosis, a benign GERD-related complication, finds optimal treatment in endoscopic dilatation coupled with PPI, yielding favorable functional outcomes Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Cherkaoui, H., Ghmari, A. E., Amine, E. M., Lahmidani, N., Benajah, D. A., Mounia, E. Y., Ibrahimi, S. A., Abkari, M. E., & Abid, H. (2024). Endoscopic treatment in peptic stenosis. Endoscopy, 56(S 02 S 02), S419. https://doi.org/10.1055/s-0044-1783751
Vancouver
Cherkaoui H, Ghmari AE, Amine EM, Lahmidani N, Benajah DA, Mounia EY, et al. Endoscopic treatment in peptic stenosis. Endoscopy. 2024;56(S 02 S 02):S419. doi:10.1055/s-0044-1783751
BibTeX
@article{Cherkaoui2024,
author = {Cherkaoui, H. and Ghmari, A. El and Amine, E. M. and Lahmidani, N. and Benajah, D. A. and Mounia, E. Y. and Ibrahimi, S. A. and Abkari, M. El and Abid, H.},
title = {Endoscopic treatment in peptic stenosis},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S419},
doi = {10.1055/s-0044-1783751}
}
EUVIMED